Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-18 | 2020-10-22 | 118247 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-01 | 2020-10-30 | 125467 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-27 | 2021-11-11 | 144755 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-09 | 2021-12-08 | 145446 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-16 | 2021-11-11 | 145791 |
| TEVA-MORPHINE SR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-10-29 | 160448 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-01 | 2023-02-09 | 176854 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-22 | 2023-02-09 | 179303 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-08 | 2023-06-27 | 194125 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-06-21 | 195210 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-04 | 2023-08-04 | 197169 |
| TEVA-MORPHINE SR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-11-08 | 2025-02-13 | 242364 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-05-22 | 2025-08-08 | 258127 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-04-03 | 2017-10-10 | 5216 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2020-11-19 | 2021-03-04 | 128603 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Actual shortage | 2023-06-08 | 2024-04-11 | 194157 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195847 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2019-10-17 | 2020-06-26 | 96727 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2019-11-28 | 2019-12-06 | 99947 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-03 | 107949 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACETAZONE FORTE C8 | 250MG 300MG 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258526 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| TEVA-DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| TEVA-DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
| TEVA-DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| TEVA-DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
| TEVA-DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT DORZOTIMOLOL | 5MG 20MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258586 |
| ACT DUTASTERIDE | 0.5MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258580 |